ArticleBMC cancer2025

The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment.

Yanchao Luan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.